Skip to main content

22-06-20 Primary Care 2

Module 20: Primary Care 2
(NPWH Activity Number 22-06-20)

Heather Quaile DNP, WHNP-BC, CSC, SANE, IF
CEO – The SHOW Center
Atlanta, GA
Adjunct Faculty – Vanderbilt University School of Nursing
Nashville, TN

Target Audience New graduate women’s health nurse practitioners (WHNPs), and other nurse practitioners involved in women’s and gender related healthcare.

Approval CE Approval Period: April 4, 2022, through April 4, 2025
Post-tests must be completed during the approval period with a passing score of 70% or higher to earn CE. No refunds will be issued if the activity is not completed within the approval period.
This activity has been approved for 1.25 continuing education contact hours

  1. Identify risk factors, signs/symptoms, and differential diagnoses related to common hematologic, immunologic, and endocrine disorders
  2. Discuss tests commonly used in the diagnosis of common hematologic, immunologic, and endocrine disorders.
  3. Describe the management of common hematologic, immunologic, and endocrine disorders. 
Content Outline
  1. Hematologic disorders: Sickle Cell Anemia, Other Anemias, Thrombocytopenia.
  2. Immunological disorders: HIV/AIDS, Systemic Lupus Erythematosus (SLE).
  3. Endocrine disorders: Diabetes 1 & 2, thyroid disorders.
  4. Other primary care: Arthritis and chronic fatigue syndrome.
Accreditation StatementThis activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH) for 1.25 continuing education contact hours.

Faculty DisclosuresHeather Quaile DNP, WHNP-BC, CSC, SANE, IF has no disclosures to report.
Successful Completion Requires participants to:
  1. Read the objectives, disclosures, and disclaimers.
  2. Watch the activity and review the handout.
  3. Complete the post-test with a score of 70% or higher.
  4. Complete the session evaluation.
  5. Print your CE certificate.
  6. Go to your profile to view all earned certificates.

Commercial Support
This activity has no commercial support.